Payment overview · 2025
General Payments
$8,182.12
89 reported records · 16 companies
Healthcare provider profile · identity verified
Karam Moon, MD
Allopathic & Osteopathic Physicians|Neurological Surgery · PHOENIX, AZ · NPI 1104147909
Verified facts
What the public records show
CMS Open Payments records show Karam Moon, MD received $8,182.12 in general payments during 2025 across 89 reported records.
Medtronic, Inc. accounted for 30.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 36 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$2,512.62 | 30.7% | 39 | 2025 |
| Alphatec Spine, Inc | Unresolved — no canonical attribution shown | $1,757.31 | 21.5% | 6 | 2025 |
| Balt USA, LLC | Unresolved — no canonical attribution shown | $1,154.29 | 14.1% | 15 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $753.30 | 9.2% | 6 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $583.27 | 7.1% | 6 | 2025 |
| Expanding Innovations, Inc. | Unresolved — no canonical attribution shown | $295.75 | 3.6% | 2 | 2025 |
| Providence Medical Technology, Inc. | Unresolved — no canonical attribution shown | $168.58 | 2.1% | 3 | 2025 |
| Innovasis Inc | Unresolved — no canonical attribution shown | $167.82 | 2.0% | 1 | 2025 |
| icotec Medical Inc. | Unresolved — no canonical attribution shown | $148.01 | 1.8% | 2 | 2025 |
| Centinel Spine, LLC | Unresolved — no canonical attribution shown | $140.09 | 1.7% | 2 | 2025 |
| Biocomposites Inc | Unresolved — no canonical attribution shown | $120.00 | 1.5% | 1 | 2025 |
| Spineart USA Inc | Unresolved — no canonical attribution shown | $112.75 | 1.4% | 1 | 2025 |
| OssDsign USA Incorporated | Unresolved — no canonical attribution shown | $90.29 | 1.1% | 1 | 2025 |
| Viseon, Inc. | Unresolved — no canonical attribution shown | $75.20 | 0.9% | 1 | 2025 |
| MML US, Inc. | Unresolved — no canonical attribution shown | $60.52 | 0.7% | 2 | 2025 |
| Intrinsic Therapeutics | Unresolved — no canonical attribution shown | $42.32 | 0.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $6,511.27 | 84 |
| Travel and Lodging | $1,670.85 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Other - Miscellaneous Normalized: other miscellaneous |
Device | Alphatec Spine, Inc | $1,670.85 | 5 | 2025 |
Source payment records
|
|||||
| Ballast 088 Long Sheath Normalized: ballast 088 long sheath |
Device | Balt USA, LLC | $699.06 | 9 | 2025 |
Source payment records
|
|||||
| TARGET Normalized: target |
Device | Stryker Corporation | $599.24 | 5 | 2025 |
Source payment records
|
|||||
| ZOOM 88-T LARGE DISTAL PLATFORM Normalized: zoom 88 t large distal platform |
Device | Imperative Care, Inc | $557.66 | 5 | 2025 |
Source payment records
|
|||||
| PIPELINE Normalized: pipeline |
Device | Medtronic, Inc. | $532.24 | 11 | 2025 |
Source payment records
|
|||||
| ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY Normalized: anteralign spinal system with titan nanolock surface technology |
Device | Medtronic, Inc. | $501.29 | 5 | 2025 |
Source payment records
|
|||||
| Prestige Coil System Normalized: prestige coil system |
Device | Balt USA, LLC | $414.38 | 5 | 2025 |
Source payment records
|
|||||
| X-PAC Normalized: x pac |
Device | Expanding Innovations, Inc. | $295.75 | 2 | 2025 |
Source payment records
|
|||||
| AXIUM PRIMETM Normalized: axium primetm |
Device | Medtronic, Inc. | $266.03 | 3 | 2025 |
Source payment records
|
|||||
| CATALYFT PL EXPANDABLE INTERBODY SYSTEM Normalized: catalyft pl expandable interbody system |
Device | Medtronic, Inc. | $247.12 | 4 | 2025 |
Source payment records
|
|||||
| KYPHON EXPRESS II KYPHOPAK TRAY Normalized: kyphon express ii kyphopak tray |
Device | Medtronic, Inc. | $187.25 | 6 | 2025 |
Source payment records
|
|||||
| SURPASS EVOLVE Normalized: surpass evolve |
Device | Stryker Corporation | $154.06 | 1 | 2025 |
Source payment records
|
|||||
| KONG-TL VBR E, EXPANDABLE BODY, L, 19 MM X 27 - 37 MM Normalized: kong tl vbr e expandable body l 19 mm x 27 37 mm |
Device | icotec Medical Inc. | $148.01 | 2 | 2025 |
Source payment records
|
|||||
| KONG-TL VBR, END PLATE, RECTANGULAR, M AND SCREW, 12 X 33 MM Normalized: kong tl vbr end plate rectangular m and screw 12 x 33 mm |
Device | icotec Medical Inc. | $148.01 | 2 | 2025 |
Source payment records
|
|||||
| KONG-TL VBR, END PLATE, ROUND, L AND SCREW, 12 X 43 MM Normalized: kong tl vbr end plate round l and screw 12 x 43 mm |
Device | icotec Medical Inc. | $148.01 | 2 | 2025 |
Source payment records
|
|||||
| VADER PEDICLE SYSTEM 6.0, SCREW, Carbon/PEEK, POLYAX., FEN., O 5.5 X 45 MM Normalized: vader pedicle system 6 0 screw carbon peek polyax fen o 5 5 x 45 mm |
Device | icotec Medical Inc. | $148.01 | 2 | 2025 |
Source payment records
|
|||||
| VADER PEDICLE SYSTEM, ROD, Carbon/PEEK, CURVED, 6.0 R450 X 200 MM Normalized: vader pedicle system rod carbon peek curved 6 0 r450 x 200 mm |
Device | icotec Medical Inc. | $148.01 | 2 | 2025 |
Source payment records
|
|||||
| PRODISC L Normalized: prodisc l |
Device | Centinel Spine, LLC | $140.09 | 2 | 2025 |
Source payment records
|
|||||
| UNID_PASS Normalized: unid pass |
Device | Medtronic, Inc. | $129.79 | 3 | 2025 |
Source payment records
|
|||||
| Stimulan Normalized: stimulan |
Device | Biocomposites Inc | $120.00 | 1 | 2025 |
Source payment records
|
|||||
| PERLA TL MIS Normalized: perla tl mis |
Device | Spineart USA Inc | $112.75 | 1 | 2025 |
Source payment records
|
|||||
| SOLITAIRE X Normalized: solitaire x |
Device | Medtronic, Inc. | $108.05 | 1 | 2025 |
Source payment records
|
|||||
| CLYDESDALE PTC SPINAL SYSTEM Normalized: clydesdale ptc spinal system |
Device | Medtronic, Inc. | $100.46 | 1 | 2025 |
Source payment records
|
|||||
| INCEPTIV Normalized: inceptiv |
Device | Medtronic, Inc. | $97.11 | 1 | 2025 |
Source payment records
|
|||||
| STEALTHSTATION S8 PLATFORM Normalized: stealthstation s8 platform |
Device | Medtronic, Inc. | $94.18 | 1 | 2025 |
Source payment records
|
|||||
| OSSDSIGN CATALYST Normalized: ossdsign catalyst |
Device | OssDsign USA Incorporated | $90.29 | 1 | 2025 |
Source payment records
|
|||||
| AQUAMANTYS(TM) Normalized: aquamantys tm |
Device | Medtronic, Inc. | $87.44 | 1 | 2025 |
Source payment records
|
|||||
| Invictus MIS Normalized: invictus mis |
Device | Alphatec Spine, Inc | $86.46 | 1 | 2025 |
Source payment records
|
|||||
| O-ARM Normalized: o arm |
Device | Medtronic, Inc. | $83.38 | 1 | 2025 |
Source payment records
|
|||||
| ADAPTIX INTERBODY SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY Normalized: adaptix interbody system with titan nanolock surface technology |
Device | Medtronic, Inc. | $78.28 | 1 | 2025 |
Source payment records
|
|||||
| MaxView System - Lateral Set Normalized: maxview system lateral set |
Device | Viseon, Inc. | $75.20 | 1 | 2025 |
Source payment records
|
|||||
| ReActiv8 Normalized: reactiv8 |
Device | MML US, Inc. | $60.52 | 2 | 2025 |
Source payment records
|
|||||
| BARRICAID ACD (ANNULAR CLOSURE DEVICE) Normalized: barricaid acd annular closure device |
Device | Intrinsic Therapeutics | $42.32 | 1 | 2025 |
Source payment records
|
|||||
| Carrier Delivery Catheter Normalized: carrier delivery catheter |
Device | Balt USA, LLC | $40.85 | 1 | 2025 |
Source payment records
|
|||||
| Raptor Aspiration Catheter Normalized: raptor aspiration catheter |
Device | Balt USA, LLC | $40.85 | 1 | 2025 |
Source payment records
|
|||||
| ZOOM REPERFUSION CATHETER Normalized: zoom reperfusion catheter |
Device | Imperative Care, Inc | $25.61 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 13 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8,182.12 · 89 records | Medtronic, Inc. | ADAPTIX INTERBODY SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY, ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY, AQUAMANTYS(TM), AXIUM PRIMETM, BARRICAID ACD (ANNULAR CLOSURE DEVICE), Ballast 088 Long Sheath, CATALYFT PL EXPANDABLE INTERBODY SYSTEM, CLYDESDALE PTC SPINAL SYSTEM, Carrier Delivery Catheter, INCEPTIV, Invictus MIS, KONG-TL VBR E, EXPANDABLE BODY, L, 19 MM X 27 - 37 MM, KONG-TL VBR, END PLATE, RECTANGULAR, M AND SCREW, 12 X 33 MM, KONG-TL VBR, END PLATE, ROUND, L AND SCREW, 12 X 43 MM, KYPHON EXPRESS II KYPHOPAK TRAY, MaxView System - Lateral Set, O-ARM, OSSDSIGN CATALYST, Other - Miscellaneous, PERLA TL MIS, PIPELINE, PRODISC L, Prestige Coil System, Raptor Aspiration Catheter, ReActiv8, SOLITAIRE X, STEALTHSTATION S8 PLATFORM, SURPASS EVOLVE, Stimulan, TARGET, UNID_PASS, VADER PEDICLE SYSTEM 6.0, SCREW, Carbon/PEEK, POLYAX., FEN., O 5.5 X 45 MM, VADER PEDICLE SYSTEM, ROD, Carbon/PEEK, CURVED, 6.0 R450 X 200 MM, X-PAC, ZOOM 88-T LARGE DISTAL PLATFORM, ZOOM REPERFUSION CATHETER | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error